Resultados de Búsqueda
t is recommended to use this guide in conjunction with other NICE guidelines to recognize, assess, and treat mental health problems in women who plan to have a baby, are pregnant or have had a baby, ...
NICE
National Institute for Health and Clinical Excellence (NICE)
Discuss with all women of childbearing potential who have a new, existing or past mental health problem: - the use of contraception and any plans for a pregnancy - how pregnancy and childbirth might affect a mental health problem, including the risk of relapse - how a mental health problem and its treatment might affect the woman, the fetus and baby - how a mental health problem and its treatment might affect parenting. [new 2014] When prescribing psychotropic medication for women of ...
ver más ... 2020Patiromer is recommended for treating hyperkalaemia in adults only if used in emergency care for acute life-threatening hyperkalaemia alongside standard care or for people with persistent ...
NICE
National Institute for Health and Clinical Excellence (NICE)
Patiromer is a treatment for people with high blood potassium levels (hyperkalaemia). It can be used for adults with chronic kidney disease (stages 3b to 5) or heart failure, either: - in emergency care alongside standard care for acute life-threatening hyperkalaemia or - In patients who have a confirmed serum potassium level of at least 6.0 mmol/litre and are not taking, or are taking a reduced dosage of, a renin-angiotensin-aldosterone system (RAAS) inhibitor because of hyperkalaemia ...
ver más ... 2020Care for adults, children and young people across all phases of bipolar disorder by improving the experience of care Use this guideline in conjunction with the NICE clinical guideline on service user ...
NICE
National Institute for Health and Clinical Excellence (NICE)
Follow the recommendations in general principles of care in the NICE clinical guideline on psychosis and schizophrenia in children and young people to improve the experience of care for children and young people with bipolar disorder.
ver más ... 2020Tinnitus: assessment and management
NICE
National Institute for Health and Clinical Excellence (NICE)
Do not offer acoustic reflex testing or uncomfortable loudness levels/loudness discomfort levels testing as part of an investigation of tinnitus. Do not offer otoacoustic emissions tests as part of an investigation of tinnitus unless the tinnitus is accompanied by other symptoms and signs. Do not offer psychoacoustic tests, for example pitch and loudness matching, to assess tinnitus. Do not offer imaging to people with symmetrical non-pulsatile tinnitus with no associated neurological, ...
ver más ... 2020Peginterferon beta‑1a is recommended, within its marketing authorisation, as an option for treating relapsing–remitting multiple sclerosis in adults.
NICE
National Institute for Health and Clinical Excellence (NICE)
Peginterferon beta‑1a is an established drug for relapsing–remitting multiple sclerosis. There is clinical trial evidence showing that the drug slows disease progression and reduces the frequency of relapses when compared with placebo. There is also an indirect comparison suggesting that there are no differences in effectiveness when comparing peginterferon beta‑1a with its main comparators, that is, other beta interferons and glatiramer acetate. However, it involves less frequent ...
ver más ... 2020